260 related articles for article (PubMed ID: 28083909)
1. Increased PLEKHO1 within osteoblasts suppresses Smad-dependent BMP signaling to inhibit bone formation during aging.
Liu J; Liang C; Guo B; Wu X; Li D; Zhang Z; Zheng K; Dang L; He X; Lu C; Peng S; Pan X; Zhang BT; Lu A; Zhang G
Aging Cell; 2017 Apr; 16(2):360-376. PubMed ID: 28083909
[TBL] [Abstract][Full Text] [Related]
2. Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts.
Wang L; Zhang X; Guo Y; Chen X; Li R; Liu L; Shi C; Guo C; Zhang Y
Cell Physiol Biochem; 2010; 26(6):1093-102. PubMed ID: 21220940
[TBL] [Abstract][Full Text] [Related]
3. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
[TBL] [Abstract][Full Text] [Related]
4. Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis.
He X; Liu J; Liang C; Badshah SA; Zheng K; Dang L; Guo B; Li D; Lu C; Guo Q; Fan D; Bian Y; Feng H; Xiao L; Pan X; Xiao C; Zhang B; Zhang G; Lu A
EBioMedicine; 2019 Mar; 41():538-555. PubMed ID: 30824383
[TBL] [Abstract][Full Text] [Related]
5. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
Taketomi T; Onimura T; Yoshiga D; Muratsu D; Sanui T; Fukuda T; Kusukawa J; Nakamura S
Cell Biol Int; 2018 Sep; 42(9):1106-1114. PubMed ID: 28921936
[TBL] [Abstract][Full Text] [Related]
6. Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis.
Liu J; Lu C; Wu X; Zhang Z; Li J; Guo B; Li D; Liang C; Dang L; Pan X; Peng S; Lu A; Zhang B; Zhang G
Sci Rep; 2017 Jan; 7():41295. PubMed ID: 28128304
[TBL] [Abstract][Full Text] [Related]
7. Mmu-miR-185 depletion promotes osteogenic differentiation and suppresses bone loss in osteoporosis through the Bgn-mediated BMP/Smad pathway.
Cui Q; Xing J; Yu M; Wang Y; Xu J; Gu Y; Nan X; Ma W; Liu H; Zhao H
Cell Death Dis; 2019 Feb; 10(3):172. PubMed ID: 30787286
[TBL] [Abstract][Full Text] [Related]
8. FOXC1 negatively regulates BMP-SMAD activity and Id1 expression during osteoblast differentiation.
Caddy JC; Luoma LM; Berry FB
J Cell Biochem; 2020 Jun; 121(5-6):3266-3277. PubMed ID: 31916318
[TBL] [Abstract][Full Text] [Related]
9. Spatial segregation of BMP/Smad signaling affects osteoblast differentiation in C2C12 cells.
Heining E; Bhushan R; Paarmann P; Henis YI; Knaus P
PLoS One; 2011; 6(10):e25163. PubMed ID: 21998639
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
11. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of BMP/Smad signaling by Tob in osteoblasts.
Yoshida Y; Tanaka S; Umemori H; Minowa O; Usui M; Ikematsu N; Hosoda E; Imamura T; Kuno J; Yamashita T; Miyazono K; Noda M; Noda T; Yamamoto T
Cell; 2000 Dec; 103(7):1085-97. PubMed ID: 11163184
[TBL] [Abstract][Full Text] [Related]
13. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
Katagiri T; Tsukamoto S
Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.
Liang C; Guo B; Wu H; Shao N; Li D; Liu J; Dang L; Wang C; Li H; Li S; Lau WK; Cao Y; Yang Z; Lu C; He X; Au DW; Pan X; Zhang BT; Lu C; Zhang H; Yue K; Qian A; Shang P; Xu J; Xiao L; Bian Z; Tan W; Liang Z; He F; Zhang L; Lu A; Zhang G
Nat Med; 2015 Mar; 21(3):288-94. PubMed ID: 25665179
[TBL] [Abstract][Full Text] [Related]
15. Class I PI-3-Kinase Signaling Is Critical for Bone Formation Through Regulation of SMAD1 Activity in Osteoblasts.
Gámez B; Rodríguez-Carballo E; Graupera M; Rosa JL; Ventura F
J Bone Miner Res; 2016 Aug; 31(8):1617-30. PubMed ID: 26896753
[TBL] [Abstract][Full Text] [Related]
16. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation.
Ishibashi O; Ikegame M; Takizawa F; Yoshizawa T; Moksed MA; Iizawa F; Mera H; Matsuda A; Kawashima H
J Cell Physiol; 2010 Feb; 222(2):465-73. PubMed ID: 19918795
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
